Dr. Zakaria Thamri
Dr. Zakaria holds a Doctoral degree in pharmacy from Algeria and a Pharmacovigilance certificate from France.
He started his career in Pharmacovigilance at Roche Pharmaceutical, where he has also served in different roles in Medical Affairs and Products Quality.
Dr. Zakaria joined Boehringer Ingelheim in February 2019 as the Local Pharmacovigilance Manager for the North-West Africa Region and is currently the regional Pharmacovigilance Lead for the IMETA region (India, Middle East, Turkey, and Africa) based in Dubai-UAE.
Dr. Zakaria Thamri
Regional Patient Safety & Pharmacovigilance Lead for India, Middle East, Turkey & Africa
Boehringer Ingelheim
Friday 7 June
Challenges and Opportunities for Pharmacovigilance Partnership with License Partners in the Emerging Markets
In some territories, Marketing Authorization holders do not always have legal entities and dedicated PV teams and they are granting rights to Local suppliers.
While it’s crucial to better understand their partners’ PV systems and the way they are complying with their responsibilities and local requirements, ensuring a good collaboration by supporting the local partners to up-scale their PV systems would be a great fix to ensure the fulfillment of the regulatory requirements and ensure Patients’ Safety.
• Whilst licensing agreements involving medicines are primarily driven by commercial considerations, the successful handling of pharmacovigilance obligations is a critical, but frequently overlooked.
• Proposal of efficient collaboration with license partners by supporting them to up-scale their PV system.
Dr. Zakaria Thamri
Regional Patient Safety & Pharmacovigilance Lead for India, Middle East, Turkey & Africa
Boehringer Ingelheim
